loader
Please Wait
Applying Filters...
menu
    • menu

    Generics: ZCL Chemicals announces successful US FDA Inspection with Zero 483 observations - Cohance Lifesciences

    MenuCohance Lifesciences

    Uploaded: 2018
    News
    Suven, Cohance to Double Business Revenue to Rs 6,000 Cr by FY29

    01 Nov 2024

    // ECONOMICTIMES

    Cohance Lifesciences merger with Suven Pharma gets NSE, BSE nod

    27 Jul 2024

    // TIMESOFINDIA

    Suven, with Cohance and more, wants to become a CDMO powerhouse

    02 Mar 2024

    // ECONOMIC TIMES

    DATA COMPILATION
    #PharmaFlow

    Cohance Lifesciences

    Contact Supplier

    Website

    Antibody Engineering

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
    Xls

    CATEGORY PAGE
    Menu

    Cohance Lifesciences

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100125